HeRo medicare GmbH

HeRo medicare GmbH, based in Mühlhausen, Germany, specializes in home healthcare services focusing on outpatient care, ensuring personalized support for clients in their residences and shared living environments. HeRo medicare GmbH was founded in 2016 in Mühlhausen, Germany, and is dedicated to providing home healthcare services. The company has not undergone any significant pivots in its business strategy. It operates independently without a parent company or subsidiaries.

In January 2026, Destia Developpement SAS, a portfolio company of Après-demain, Siparex, Azulis Capital, BNP Paribas Developpement, Carvest, MACSF, and Societe Generale Capital Partenaires, acquired a 70% majority stake in HeRo medicare GmbH. HeRo medicare offers a range of home healthcare services primarily focused on outpatient care in Mühlhausen, Thüringen. The company specializes in providing care for clients in their homes, including non-clinical intensive care for patients in shared living environments and personal settings. The service offerings encompass support for seniors living in communal settings, as well as domestic assistance for over 200 clients, ensuring a reliable care experience.

HeRo medicare emphasizes the selection of skilled professionals with strong social competencies to meet the diverse needs of their clientele, primarily directed towards local residents in Mühlhausen and surrounding areas. HeRo medicare generates revenue through direct transactions with clients and their families for various healthcare services, structured primarily as fee-for-service agreements. Clients are billed for specific services rendered, such as outpatient care and domestic assistance. The pricing structure caters to different client needs, offering tailored packages that may include routine healthcare visits, intensive care support, and housekeeping services.

The company's commitment to high-quality care fosters long-term relationships with clients, enhancing customer retention and satisfaction, which plays a critical role in its operational model and financial health. Following the acquisition by Destia Developpement SAS in January 2026, HeRo medicare plans to enhance its business development. This strategic move may facilitate the introduction of new services and the expansion into broader markets. Specific upcoming products and their launch dates have not been disclosed, but the acquisition is expected to support these initiatives, positioning HeRo medicare for further growth in the home healthcare sector.